Defense Date
10-12-2011
Graduation Date
Spring 2011
Availability
Immediate Access
Submission Type
thesis
Degree Name
MS
Department
Pharmacy Administration
School
School of Pharmacy
Committee Chair
Khalid M. Kamal
Committee Member
Jennifer Elliott
Committee Member
Gibbs Kanyongo
Keywords
Asthma, COPD, Cost
Abstract
Objective: To estimate national prevalence and direct incremental expenditures in Chronic Obstructive Pulmonary Disease (COPD) and asthma using 2007 Medical Expenditure Panel Survey (MEPS) data.
Methods: COPD and asthma were identified using ICD-9 codes and were the main independent variables. Covariates included age, gender, race, income, region, insurance and marital status. Dependent variables were total health care, office-based, outpatient, inpatient, emergency room and prescription expenditures. Descriptive statistics and regression analysis were used to fulfill the study objectives.
Results: Prevalence of COPD and asthma was 1.3 million and 28.3 million, respectively. Total direct incremental health care expenditures per person for COPD and asthma were $1,739.27 and $2,133.83, respectively. High cost categories among COPD and asthma included office-based, inpatient and prescription expenditures. Age, gender, region, insurance and marital status were significant predictors for health care expenditures.
Conclusion: Results highlight socio-demographic disparities and high health care expenditures due to COPD and asthma in the United States.
Format
Language
English
Recommended Citation
Srivastava, B. (2011). Direct Incremental Costs in Chronic Obstructive Pulmonary Disease (COPD) and Asthma in United States - An Analysis of 2007 Medical Expenditure Panel Survey Data (Master's thesis, Duquesne University). Retrieved from https://dsc.duq.edu/etd/1232